Kingstone director sells 13,500 shares at $18

Kingstone Companies, Inc. director William L. Yankus sold 13,500 shares of Common Stock at $18.00 per share in an open-market transaction.

Rhea-AI Filing Summary

Kingstone Companies, Inc. director William L. Yankus sold 13,500 shares of Common Stock at $18.00 per share in an open-market transaction. After this sale, he directly holds 84,972 shares, including 3,149 unvested shares received as director fees. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 8, 2025, indicating the trade was scheduled in advance rather than timed discretionarily.

Insider Trade Summary 10b5-1

Net Seller: 13,500 shares

Net Sell 1 txn

Insider Yankus William L

Role Director

Sold 13,500 shs ($243K)

Type	Security	Shares	Price	Value
Sale	Common Stock	13,500	$18.00	$243K

Holdings After Transaction: Common Stock — 84,972 shares (Direct)

Footnotes (2)

1. F1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025.
2. F2. Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.

Key Figures

Shares sold: 13,500 shares Sale price: $18.00 per share Shares held after sale: 84,972 shares +3 more

6 metrics

Shares sold 13,500 shares Open-market sale of Common Stock on April 16, 2026

Sale price $18.00 per share Price for 13,500 shares of Common Stock

Shares held after sale 84,972 shares Direct holdings of William L. Yankus following transaction

Unvested director fee shares 3,149 shares Included in post-transaction holdings as unvested awards

Vesting date January 2, 2027 Scheduled vesting date for 3,149 unvested shares

10b5-1 plan adoption date September 8, 2025 Date reporting person adopted Rule 10b5-1 trading plan

Key Terms

Rule 10b5-1 trading plan, unvested shares, director fees, open-market sale

4 terms

Rule 10b5-1 trading plan regulatory

"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted..."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

unvested shares financial

"Includes 3,149 unvested shares received as director fees."

director fees financial

"Includes 3,149 unvested shares received as director fees."

open-market sale financial

"transaction_action: "open-market sale" for 13,500 shares of Common Stock"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did KINGSTONE COMPANIES, INC. (KINS) report?

KINGSTONE COMPANIES, INC. reported that director William L. Yankus sold 13,500 shares of Common Stock at $18.00 per share. This was an open-market transaction and was disclosed in a Form 4 insider trading report filed with the SEC.

How many KINS shares did William L. Yankus sell and at what price?

William L. Yankus sold 13,500 shares of KINGSTONE COMPANIES, INC. Common Stock at $18.00 per share. The sale was categorized as an open-market transaction and was executed under a previously adopted Rule 10b5-1 trading plan.

How many KINS shares does William L. Yankus hold after this sale?

After the sale, William L. Yankus directly holds 84,972 shares of KINGSTONE COMPANIES, INC. Common Stock. This amount includes 3,149 unvested shares that were received as director fees and remain subject to their vesting schedule.

Was the KINS insider sale made under a Rule 10b5-1 trading plan?

Yes. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by William L. Yankus on September 8, 2025. Such plans pre-schedule trades, reducing the likelihood that timing reflects short-term views on the stock.

What are the unvested KINS shares mentioned in the Form 4 filing?

The Form 4 notes that 3,149 of William L. Yankus’s KINGSTONE COMPANIES, INC. shares are unvested director fee shares. These shares are scheduled to vest on January 2, 2027, subject to certain conditions that could allow earlier vesting.

What type of security was involved in the KINS Form 4 transaction?

The transaction involved KINGSTONE COMPANIES, INC. Common Stock. It was a non-derivative open-market sale of 13,500 shares at $18.00 per share, reported as a standard equity transaction rather than an option or other derivative exercise.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/17/2026 - 04:36 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yankus William L

(Last) (First) (Middle)

10 PHEASANT HILL ROAD

(Street)

FARMINGTON CONNECTICUT 06032

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KINGSTONE COMPANIES, INC. [ KINS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/16/2026		S(1)		13,500	D	$18	84,972(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025.

2. Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.

	/s/ William L. Yankus	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)